Stay updated on Nivolumab and Temozolomide in Small-Cell Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the Nivolumab and Temozolomide in Small-Cell Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab and Temozolomide in Small-Cell Lung Cancer Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    Change Detected
    Summary
    A sitewide notice about NIH terminology and transition updates was removed from the top of the page. The study record area still shows a 403 Forbidden error.
    Difference
    1%
    Check dated 2026-11-07T16:40:04.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    The footer now identifies the ClinicalTrials.gov revision as v3.8.0 instead of v3.7.2. The study record continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-31T16:49:10.000Z thumbnail image
  4. Check
    21 days ago
    Change Detected
    Summary
    A notice appears above the page announcing NIH website-transition updates and explaining that some content may use “Super Intelligence” in place of “Artificial Intelligence.”
    Difference
    1%
    Check dated 2026-10-24T20:22:45.000Z thumbnail image
  5. Check
    28 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changed from v3.7.1 to v3.7.2. The study page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-17T21:57:18.000Z thumbnail image
  6. Check
    35 days ago
    Change Detected
    Summary
    The site revision identifier changed from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T22:04:15.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error page with the site header and a Home button, indicating access to the study record is blocked.
    Difference
    20%
    Check dated 2026-09-19T21:59:22.000Z thumbnail image

Stay in the know with updates to Nivolumab and Temozolomide in Small-Cell Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab and Temozolomide in Small-Cell Lung Cancer Clinical Trial page.